US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

163.21

-2.5200-1.52%

Volume:3.37M

Turnover:549.41M

Market Cap:11.35B

PE:8.95

High:165.55

Open:165.15

Low:161.49

Close:165.73

52wk High:169.68

52wk Low:88.60

Shares:69.53M

Float Shares:69.53M

Volume Ratio:1.81

T/O Rate:4.85%

Dividend:0.56

Dividend Rate:0.35%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

J.P. Morgan Remains a Buy on Fortis Healthcare Ltd. (FORTIS)

Analyst Maintains Buy on NGN-401 After Strong Rett Data and Cleared Safety Window, Trims Price Target to $63

Sector Update: Healthcare

MT Newswires Live

Legend Biotech Shares Rise After Swinging to 2Q Profit, Higher Revenue

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101

Analysts’ Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)

DRI Healthcare Trust Collects $178M for Ekterly Royalty Exit

Incannex Secures A$5.1M R&D Tax Incentive Refund

Press Release: DRI Healthcare Announces Receipt of Put Price on Ekterly

YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

Goldman Sachs, TCGX Lead $152 Million Investment Round in Swiss Biotech Vaderis

Legend Biotech Q2 Adj. EPS $0.16 Beats $0.07 Estimate, Sales $387.500M Beat $355.772M Estimate

Benzinga Earnings

Sansure Biotech's Shareholder Receives Court Approval to Offload Part of Stake as Debt Payment

MT Newswires Live

North American Morning Briefing: Stock Futures Flat, Oil up as Inflation Worries Rattle the Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/XBI/news?page=18"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":163.21,"timestamp":1787582375536,"preClose":165.73,"halted":0,"volume":3374702,"delay":0,"changeRate":-0.015205454655161902,"floatShares":69525000,"shares":69525000,"eps":18.23,"marketStatus":"Trading","change":-2.52,"latestTime":"08-24 10:39:36 EDT","open":165.15,"high":165.55,"low":161.49,"amount":549408201.25698,"amplitude":0.024498,"askPrice":163.25,"askSize":650,"bidPrice":163.16,"bidSize":370,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":165.73,"sharesOutstanding":63325000,"nav":165.682052,"aum":11336794406.12,"dividendRate":0.003453,"bidAskSpread":0.000298,"preHourTrading":{"tag":"盘前","latestPrice":165.16,"preClose":165.73,"latestTime":"09:29 EDT","volume":10879,"amount":1802405.0873399999,"timestamp":1787578199999,"change":-0.57,"changeRate":-0.003439,"amplitude":0.007898},"postHourTrading":{"tag":"盘后","latestPrice":166.35,"preClose":165.73,"latestTime":"19:59 EDT","volume":85473,"amount":14172263.124,"timestamp":1787356794970,"change":0.62,"changeRate":0.003741,"amplitude":0.005008},"volumeRatio":1.80711,"impliedVol":0.3244,"impliedVolPercentile":0.7092},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":69525000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.80711,"shares":69525000,"dividePrice":0.5635,"high":165.55,"amplitude":0.024498,"preClose":165.73,"low":161.49,"week52Low":88.6,"pbRate":"--","week52High":169.68,"institutionHeld":0.8511,"latestPrice":163.21,"committee":-0.27451,"eps":18.23,"divideRate":0.003453,"volume":3374702,"delay":0,"ttmEps":18.23,"open":165.15,"prevYearClose":121.93,"prevWeekClose":165.73,"prevMonthClose":147.01,"prevQuarterClose":158.25,"fiveDayClose":159.53,"twentyDayClose":150.59,"sixtyDayClose":135.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:18,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658433917","title":"Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658433917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658433917?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:10","pubTimestamp":1786471809,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Relmada Therapeutics (RLMD), Surgery Partners (SGRY) and Apogee T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-relmada-therapeutics-rlmd-surgery-partners-sgry-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","BK4137","LU0128526141.USD","XBI","BK4007","XLV","LU0053671581.USD","BK4185","SGRY","BK4588","LABU","LU0029874061.USD","PSIL","BK4139","RLMD","SBIO","APGE","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658791274","title":"Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658791274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658791274?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:40","pubTimestamp":1786470008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Bi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immunic-imux-legend-biotech-legn-and-sagimet-biosciences-inc-class-a-sgmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","CANC","HCSG","BK4585","IMUX","LEGN","MEDI","MEMS","XLV","LABU","BK4581","BK4139","BK4505","BK4137","LU0029874061.USD","SGMT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912744","title":"J.P. Morgan Remains a Buy on Fortis Healthcare Ltd. (FORTIS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912744","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912744?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469755,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Bansi Desai maintained a Buy rating on Fortis Healthcare Ltd. yesterday and set a price target of INR1,180.00. The company’s sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-fortis-healthcare-ltd-fortis-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-fortis-healthcare-ltd-fortis-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IAI","LABU","LU0106831901.USD","BK4534","LU0971096721.USD","LU1244550577.SGD","LU0528227936.USD","LU1989772923.USD","LU1162221912.USD","IE00B775SV38.USD","LU2347655156.SGD","LU2487616109.SGD","LU0390134368.USD","IE00BKVL7J92.USD","LU1363072403.SGD","XBI","LU2133065610.SGD","LU0912757837.SGD","LU2089283258.USD","LU0158827781.USD","BK4516","LU0795875169.SGD","LU0029874061.USD","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU0006306889.USD","LU1732800096.USD","HCSG","LU1074936037.SGD","LU2271345857.HKD","LU0158827948.USD","BK4137","BK4585","LU1548497426.USD","LU0225283273.USD","LU1720051108.HKD","LU0234570918.USD","LU2023251221.USD","KBWB","LU0210528500.USD","XLV","LU0106261372.USD","LU0882574139.USD","LU1720051017.SGD","IE00B3S45H60.SGD","LU0320765646.SGD","LU2111349929.HKD","LU1791710582.SGD","LU1668664300.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658291273","title":"Analyst Maintains Buy on NGN-401 After Strong Rett Data and Cleared Safety Window, Trims Price Target to $63","url":"https://stock-news.laohu8.com/highlight/detail?id=2658291273","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658291273?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:35","pubTimestamp":1786469744,"startTime":"0","endTime":"0","summary":"Neurogene, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Dolezal from LifeSci Capital maintained a B...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-ngn-401-after-strong-rett-data-and-cleared-safety-window-trims-price-target-to-63-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-ngn-401-after-strong-rett-data-and-cleared-safety-window-trims-price-target-to-63-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","XBI","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658644912","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2658644912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658644912?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:15","pubTimestamp":1786468518,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index shedding 0.6% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.4%.The iShares Biotechnology ETF  rose 0.3%In corporate news, Hims & Hers Health  shares were down 3.8% following its Q2 results. The results were mixed, with upside in its US business from branded GLP-1 strength and a ramp in testosterone offset by disappointing gross margin and weak free cash flow, Morgan Stanley said in a note.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1074936037.SGD","LU0158827781.USD","LU0390134368.USD","LU1732799900.SGD","LU1668664300.SGD","LU1989772923.USD","KBWB","LU2089283258.USD","HEAL","LU2089284900.SGD","LU2271345857.HKD","LU0053666078.USD","LU0106831901.USD","LU0267386448.USD","LU0528227936.USD","GLAM","HIMS","LU2028103732.USD","HIYY","LU1791710400.SGD","LU0971096721.USD","BK4504","LU2023251221.USD","LU1732800096.USD","LU1791710582.SGD","THNR","LU0210528500.USD","BK4585","BK4588","IE00BZ1G4Q59.USD","XBI","LU0098860793.USD","LU0320765646.SGD","LU2264538146.SGD","IBB","LU1162221912.USD","LU2357305700.SGD","IE00B3S45H60.SGD","IAI","BK4516","LU2133065610.SGD","LU0225283273.USD","XLV","LU1064131342.USD","IE00BKVL7J92.USD","LU0314104364.USD","BK4534","BK4127","HMYY","LU1720051108.HKD","BK4196","LU0557290698.USD","LU0795875086.SGD","LU0106261372.USD","LU0882574139.USD","BK4581","LU0006306889.USD","LU2347655156.SGD","LU1244550221.USD","HIMZ","HIMY","LU1363072403.SGD","LU2487616109.SGD","LABU","MS","LU2111349929.HKD","LU0795875169.SGD","LU0234570918.USD","IE00B775SV38.USD","LU1244550494.USD","LU0912757837.SGD","LU1988902786.USD","LU1720051017.SGD","LU0158827948.USD","LU1244550577.SGD","LU1548497426.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658257911","title":"Legend Biotech Shares Rise After Swinging to 2Q Profit, Higher Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2658257911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658257911?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:41","pubTimestamp":1786462860,"startTime":"0","endTime":"0","summary":"Shares of Legend Biotech rose after the biopharmaceutical company swung to a second quarter profit and posted higher revenue.The stock was up 6.4% to $22.06 in late morning trading on Tuesday, and is now up 1.5% this year.The company posted net income of $33.2 million, or 9 cents a share, compared with a loss of $125.4 million, or 34 cents a share, a year earlier.Revenue rose to $387.5 million from $255.1 million, driven by sales of Carvykti, an immunotherapy used to treat cancer of the bone marrow, known as multiple myeloma. Analysts polled by FactSet expected $356 million.Interim Chief Executive Alan Bash said Carvykti expanded globally during the quarter and commercial momentum of Carvykti provided the foundation to advance a diversified portfolio of cell therapies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911286","title":"Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911286?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:40","pubTimestamp":1786462847,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurosense Therapeutics Ltd. (NRSN) and Brookdale Se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-and-brookdale-senior-living-bkd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRSN","BK4185","BK4588","LABU","LU0029874061.USD","LU0128526141.USD","BK4139","LU2190626999.HKD","LU1499592464.USD","BK4137","BK4581","LU0842063009.USD","XLV","BK4585","XBI","BKD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658064919","title":"Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658064919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658064919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:00","pubTimestamp":1786460418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardinal Health (CAH), Axsome Therapeutics (AXSM) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1880398554.USD","BK4007","LU0310800965.SGD","XBI","LU0029874061.USD","LU0154236417.USD","HCSG","LU0211328371.USD","SG9999001440.SGD","BK4139","LU1983299246.USD","AXSM","BK4581","LU0211327993.USD","LU2324357040.USD","LU0128526141.USD","LU0128525689.USD","LU0310799852.SGD","BK4585","BK4588","LU1267930490.SGD","LU0006061336.USD","BBIO","BK4137","LU0162691827.USD","LABU","BK4505","XLV","CAH","LU0889566641.SGD","LU0072461881.USD","LU1571399168.USD","LU1267930813.SGD","LU0052756011.USD","BK4175","LU0792757196.USD","LU1880398471.USD","LU1267930227.SGD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916594","title":"Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916594?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:50","pubTimestamp":1786456215,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TE...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-sonida-senior-living-snda-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-sonida-senior-living-snda-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4581","BK4137","BK4185","HCSG","LU0128526141.USD","SNDA","XBI","RCKT","TELA","BK4585","XLV","BK4588","LU0029874061.USD","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913504","title":"Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913504","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913504?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:00","pubTimestamp":1786453226,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","XLV","LU2756315318.SGD","LU0353189680.USD","LU2756315664.SGD","LU0320765992.SGD","LU2417539215.USD","BIB","TBXU","VRTX","UXI","TRUI","MISL","LGHT","LU0820561909.HKD","LU1261432733.SGD","IBB","BBH","LU1084165304.USD","IDNA","AGIO","VERX","XBI","NATO","BK4139","LU0058720904.USD","METV","LU0267386448.USD","SG9999001176.SGD","IE0002270589.USD","LU0157215616.USD","BK4588","ITA","LABU","LU0757428866.USD","GNMX","XAR","LU0417517546.SGD","EXI","LU1093756325.SGD","LU2089984988.USD","IE00B19Z9P08.USD","DFEN","IBBQ","IE0009355771.USD","PBE","PPA","GEHC","GE","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658399001","title":"PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101","url":"https://stock-news.laohu8.com/highlight/detail?id=2658399001","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658399001?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:25","pubTimestamp":1786451100,"startTime":"0","endTime":"0","summary":"PDS0301 Phase 2 clinical data in mCRC and a comprehensive review of capital allocation priorities drive strategic refocus designed to maximize long-term shareholder valuePRINCETON, N.J., Aug.  11, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342690/37149/en/pds-biotech-announces-strategic-refocus-prioritizing-pds0301-in-metastatic-colorectal-cancer-mcrc-and-partnership-strategy-for-pds0101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","ORR","BK4588","PDS","MSS","BK4092","BK4585","XBI","IDNA","BK4113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658899073","title":"Analysts’ Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658899073","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658899073?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:20","pubTimestamp":1786450836,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Qiagen (QGEN) and Establishment Labs Holdings (ESTA)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-qiagen-qgen-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-qiagen-qgen-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4121","HCSG","LU1923622614.USD","LU2433249047.HKD","BK4588","LU0128526141.USD","ESTA","XBI","BK4137","LABU","QGEN","LU2324357040.USD","LU2125909593.SGD","XLV","BK4581","BK4585","LU0029874061.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990417","title":"DRI Healthcare Trust Collects $178M for Ekterly Royalty Exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990417","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990417?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:19","pubTimestamp":1786450740,"startTime":"0","endTime":"0","summary":"DRI Healthcare Trust has cashed out of its royalty investment in the drug Ekterly, collecting about $178 million.The Toronto-based healthcare fund on Tuesday said it exercised a contractual option to sell back its royalty rights following Chiesi Group's takeover of KalVista Pharmaceuticals, the developer of Ekterly.In June, Italian pharmaceutical firm Chiesi Group acquired KalVista Pharmaceuticals, the developer of Ekterly, an oral medication developed for hereditary angioedema, for about $1.9 billion.The takeover triggered a contractual put option clause, giving DRI Healthcare the right to compel the buyer to repurchase its royalty stake rather than continuing to hold the long-term royalty stream.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4504","BK4209","HCSG","LABU","BK4588","LU0154245673.USD","BK4137","BK4585","XBI","LU0128526141.USD","BK4581","DRI","LU0029874061.USD","LU0154245756.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990558","title":"Incannex Secures A$5.1M R&D Tax Incentive Refund","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990558","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990558?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:01","pubTimestamp":1786449679,"startTime":"0","endTime":"0","summary":"Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) has issued an update. On August 11, 2026, Incannex Healthcare announced it had received a fin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/incannex-secures-a5-1m-rd-tax-incentive-refund?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/incannex-secures-a5-1m-rd-tax-incentive-refund?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARMH","CVY","DINT","LABU","AADR","APIE","DIVL","XLV","XBI","SAPH","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990828","title":"Press Release: DRI Healthcare Announces Receipt of Put Price on Ekterly","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990828","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990828?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449600,"startTime":"0","endTime":"0","summary":"TORONTO, Aug. 11, 2026 /CNW/ -- DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (\"DRI Healthcare\") today announced that it has received the Put Price of approximately US$178 million in connection with","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU0154245756.USD","BK4209","BK4137","LABU","HCSG","XBI","DRI","LU0128526141.USD","BK4585","LU0029874061.USD","XLV","LU0154245673.USD","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990405","title":"YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990405","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990405?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:00","pubTimestamp":1786449600,"startTime":"0","endTime":"0","summary":"Two chrono-nutrition formulations — a daytime lipid-soluble “Golden Triangle” formula and a nighttime zinc-plus-calcium formula — were developed in collaboration with the Taiwan CDHA and FHI. The Comp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342671/0/en/yd-bio-launches-a-physician-partnership-initiative-in-taiwan-with-the-announcement-of-two-nutraceutical-products-in-collaboration-with-the-taiwan-chronic-disease-healthcare-associa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","NOBL","BK4550","BK4137","CGCV","HCSG","BK4585","BK4588","LU0128526141.USD","VHT","TCAF","LU0029874061.USD","IXJ","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997390","title":"Goldman Sachs, TCGX Lead $152 Million Investment Round in Swiss Biotech Vaderis","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997390","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997390?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:34","pubTimestamp":1786448040,"startTime":"0","endTime":"0","summary":"Swiss biotech company Vaderis Therapeutics said it raised $152 million in a funding round jointly led by Goldman Sachs Alternatives' life-sciences arm and healthcare investor TCG Crossover that will h","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","LU0251131958.USD","LU2471134879.HKD","LU1868837300.USD","LU2471134796.USD","BK4588","TCGX","BK4550","BK4552","LU1894683348.USD","IE0004091025.USD","LU0096364046.USD","IE00BSNM7G36.USD","LU0251142724.SGD","IE0004086264.USD","LU1804176565.USD","BK4516","LU2237443622.USD","LU2471134523.USD","LU1791807156.HKD","LU0868494617.USD","LU1868836757.USD","LU1868836914.USD","LU1668664300.SGD","BK4533","BK4581","LU0942090050.USD","LU1894683264.USD","LU2237443895.HKD","LU0345770993.USD","LU2265009873.SGD","LU1868837136.USD","BK4585","LU2471134952.CNY","LU2750360641.GBP","LU2237443978.SGD","IE0034235188.USD","LU2237438978.USD","DBB","GS","XBI","LU0106831901.USD","IE0002270589.USD","LU2237443382.USD","BK4127","IE00B19Z3B42.SGD","LU0048573561.USD","LU0868494708.USD","GSX","LU1868836591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994723","title":"Legend Biotech Q2 Adj. EPS $0.16 Beats $0.07 Estimate, Sales $387.500M Beat $355.772M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994723","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994723?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:02","pubTimestamp":1786446169,"startTime":"0","endTime":"0","summary":"Legend Biotech (NASDAQ:LEGN) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.07 by 100 percent. This is a 147.06 percent increase over losses of $(0.34) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61102947/legend-biotech-q2-adj-eps-0-16-beats-0-07-estimate-sales-387-500m-beat-355-772m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658750999","title":"Sansure Biotech's Shareholder Receives Court Approval to Offload Part of Stake as Debt Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2658750999","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658750999?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:06","pubTimestamp":1786442805,"startTime":"0","endTime":"0","summary":"Sansure Biotech  said a court ruled that a shareholder would be allowed to dispose of some of his shares in the company to pay debts to the entities he controlled, according to a Shanghai bourse filing on Tuesday.The Intermediate People's Court of Zhuzhou City, Hunan Province, China permitted Chen Wenyi, a shareholder owning 5% of the biotechnology company, to sell 5.7 million shares, or 0.99% of the company's total shares, through block trades or centralized bidding.Chen's holdings will be reduced to 3.58% from 4.56%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","688289","BK4581","XBI","BK4585","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599979","title":"North American Morning Briefing: Stock Futures Flat, Oil up as Inflation Worries Rattle the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599979?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:00","pubTimestamp":1786442400,"startTime":"0","endTime":"0","summary":"Stock futures were steady Tuesday as investors remained cautious ahead ofinflation data and developments in the Middle East.Brent extended the previous session's gains, trading at nearly $90 a barrel,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","VTV","RULE","BAMA","PMDE","LABU","CGDV","AFG","BK4615","XLV","UFO","BK4535","SMHU","HIDV","VOTE","SMH","BK4581","DXYZ","EQRR","PLGI","BK4107","FT","DECU","BK4585","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":18,"totalSize":382,"code":"91000000","status":"200"}]}}